Нүүр зураг

NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer

Background: Non-alcoholic fatty liver disease (NAFLD) has gradually emerged as the most prevalent cause of chronic liver diseases. However, specific changes during the progression of NAFLD from non-fibrosis to advanced fibrosis and then hepatocellular carcinoma (HCC) are unresolved. Here, we firstly...

Бүрэн тодорхойлолт

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Taofei Zeng (Зохиогч), Guanglei Chen (Зохиогч), Xinbo Qiao (Зохиогч), Hui Chen (Зохиогч), Lisha Sun (Зохиогч), Qingtian Ma (Зохиогч), Na Li (Зохиогч), Junqi Wang (Зохиогч), Chaoliu Dai (Зохиогч), Feng Xu (Зохиогч)
Формат:	Ном
Хэвлэсэн:	Frontiers Media S.A., 2022-04-01T00:00:00Z.
Нөхцлүүд:	article
Онлайн хандалт:	Connect to this object online.
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes
-н: Xinbo Qiao, зэрэг
Хэвлэсэн: (2023)

The NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients
-н: Sombat Treeprasertsuk
Хэвлэсэн: (2013)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
-н: Sisi Lei, зэрэг
Хэвлэсэн: (2022)

Predictors of NAFLD rapidly progression in type 2 diabetes patients
-н: G. Mykhalchyshyn
Хэвлэсэн: (2020)

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
-н: Yuan-Ye Qiu, зэрэг
Хэвлэсэн: (2023)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
-н: Ameng Shi, зэрэг
Хэвлэсэн: (2021)

NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
-н: Ming-Feng Xia, зэрэг
Хэвлэсэн: (2019)

Nutritional Intake and the Risk for Non-alcoholic Fatty Liver Disease (NAFLD)
-н: Jörn M. Schattenheim (Ed.)
Хэвлэсэн: (2019)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
-н: Patrycja Walczak, зэрэг
Хэвлэсэн: (2023)

Effects of various interventions on non-alcoholic fatty liver disease (NAFLD): A systematic review and network meta-analysis
-н: Xinchen Wang, зэрэг
Хэвлэсэн: (2023)

Treatments for NAFLD
-н: Katarzyna Juszczyńska
Хэвлэсэн: (2021)

Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
-н: Arash Dooghaie Moghadam, зэрэг
Хэвлэсэн: (2020)

Non-Alcoholic Fatty Liver Disease (NAFLD) in overweight and obese children and adolescents
-н: Ralf Schiel, зэрэг
Хэвлэсэн: (2020)

Nonalcoholic Fatty Liver Disease (NAFLD) And Cardiovascular Risk In Renal Transplant Recipients
-н: Ivana Mikolasevic, зэрэг
Хэвлэсэн: (2014)

Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD
-н: C. Busca, зэрэг
Хэвлэсэн: (2022)

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
-н: Kalliopi Pafili, зэрэг
Хэвлэсэн: (2021)

Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
-н: Guoyi Tang, зэрэг
Хэвлэсэн: (2021)

Comparison of MAFLD and NAFLD Characteristics in Children
-н: Yunfei Xing, зэрэг
Хэвлэсэн: (2023)

Involvement of Intracellular TAGE and the TAGE-RAGE-ROS Axis in the Onset and Progression of NAFLD/NASH
-н: Akiko Sakasai-Sakai, зэрэг
Хэвлэсэн: (2023)

Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression
-н: Eveline Bruinstroop, зэрэг
Хэвлэсэн: (2021)

Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score
-н: Yun Seo Jang, зэрэг
Хэвлэсэн: (2023)

Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice
-н: Songtao Li, зэрэг
Хэвлэсэн: (2020)

Non-alcohlic Fatty Liver Disease (NAFLD): Is it a Dormant Volcano or Tip of an Iceberg?
-н: Prashasti Gupta
Хэвлэсэн: (2024)

Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes
-н: Rohitash Jamwal, зэрэг
Хэвлэсэн: (2020)

Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues
-н: Zhenwang Nie, зэрэг
Хэвлэсэн: (2024)

Sex hormone binding globulin (SHBG) as a predictor of liver fibrosis in subjects with nonalcoholic fatty liver disease (NAFLD)
-н: Abeer Abdel-latif, зэрэг
Хэвлэсэн: (2023)

Role of fatty acids in pathogenetic mechanisms of NAFLD progression among type 2 diabetes patients
-н: G. Mykhalchyshyn
Хэвлэсэн: (2020)

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
-н: Chuangzhen Lin, зэрэг
Хэвлэсэн: (2022)

The Effects of Olive Oil on Non-Alcoholic Fatty Liver Disease (NAFLD) in Male Wistar Rats
-н: Arefeh Khaksar Jalali, зэрэг
Хэвлэсэн: (2017)

Dietary Selenium Alleviated Mouse Liver Oxidative Stress and NAFLD Induced by Obesity by Regulating the KEAP1/NRF2 Pathway
-н: Yi Wang, зэрэг
Хэвлэсэн: (2022)

Polygoni Cuspidati Rhizoma et Radix extract attenuates high-fat diet-induced NAFLD in rats: Impact on untargeted serum metabolomics and liver lipidomics
-н: Huan Zhang, зэрэг
Хэвлэсэн: (2023)

Genetic implications in patients with NAFLD
-н: Jakub Misiak, зэрэг
Хэвлэсэн: (2024)

Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
-н: Gretchen Wolff, зэрэг
Хэвлэсэн: (2022)

Comparing Effects of Medication Therapy and Exercise Training with Diet on Liver enzyme Levels and Liver Sonography in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
-н: Azadeh Nabizadeh Haghighi, зэрэг
Хэвлэсэн: (2015)

Altered local RAS in the liver increased the risk of NAFLD in male mouse offspring produced by in vitro fertilization
-н: Le Bo, зэрэг
Хэвлэсэн: (2023)

Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients
-н: Ali Khan R, зэрэг
Хэвлэсэн: (2017)

Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
-н: Lu Wang, зэрэг
Хэвлэсэн: (2023)

Non-alcoholic fatty liver disease (NAFLD) and obesity in inflammatory bowel disease (IBD) patients in Gorgan
-н: Sima Besharat, зэрэг
Хэвлэсэн: (2024)

Higher BMI predicts liver fibrosis among obese children and adolescents with NAFLD - an interventional pilot study
-н: Hadar Moran-Lev, зэрэг
Хэвлэсэн: (2021)

PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
-н: Qiao H, зэрэг
Хэвлэсэн: (2023)